1,2-dihydroxy-3-methyl-anthracene-9,10-dioneCAS# 602-63-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 602-63-1 | SDF | Download SDF |
PubChem ID | 429241 | Appearance | Yellow cryst. |
Formula | C15H10O4 | M.Wt | 254.2 |
Type of Compound | Anthraquinones | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1,2-dihydroxy-3-methylanthracene-9,10-dione | ||
SMILES | CC1=C(C(=C2C(=C1)C(=O)C3=CC=CC=C3C2=O)O)O | ||
Standard InChIKey | QPAGCTACMMYJIO-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
1,2-dihydroxy-3-methyl-anthracene-9,10-dione Dilution Calculator
1,2-dihydroxy-3-methyl-anthracene-9,10-dione Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.9339 mL | 19.6696 mL | 39.3391 mL | 78.6782 mL | 98.3478 mL |
5 mM | 0.7868 mL | 3.9339 mL | 7.8678 mL | 15.7356 mL | 19.6696 mL |
10 mM | 0.3934 mL | 1.967 mL | 3.9339 mL | 7.8678 mL | 9.8348 mL |
50 mM | 0.0787 mL | 0.3934 mL | 0.7868 mL | 1.5736 mL | 1.967 mL |
100 mM | 0.0393 mL | 0.1967 mL | 0.3934 mL | 0.7868 mL | 0.9835 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Thiocolchicoside
Catalog No.:BCN8442
CAS No.:602-41-5
- Taspine
Catalog No.:BCN6956
CAS No.:602-07-3
- Licoflavonol
Catalog No.:BCN6828
CAS No.:60197-60-6
- Methyl 15-hydroxy-7-oxodehydroabietate
Catalog No.:BCN7674
CAS No.:60188-95-6
- Corypalmine
Catalog No.:BCN4111
CAS No.:6018-40-2
- Arecaidine hydrochloride
Catalog No.:BCN8530
CAS No.:6018-28-6
- Sodium 4-Aminosalicylate
Catalog No.:BCC4609
CAS No.:6018-19-5
- TWS119
Catalog No.:BCC4512
CAS No.:601514-19-6
- 11,12-Dihydro-7-hydroxyhedychenone
Catalog No.:BCN7382
CAS No.:60149-07-7
- Gabapentin
Catalog No.:BCC3783
CAS No.:60142-96-3
- Gabapentin HCl
Catalog No.:BCC4502
CAS No.:60142-95-2
- Cephaelin dihydrobromide
Catalog No.:BCC8142
CAS No.:6014-81-9
- Coptisine chloride
Catalog No.:BCN6321
CAS No.:6020-18-4
- Altamycin A
Catalog No.:BCN1823
CAS No.:60202-22-4
- Oleanolic acid-3-O-beta-D-glucopyranosyl (1→2)-alpha-L-arabinopyranoside
Catalog No.:BCN1406
CAS No.:60213-69-6
- AZD-5438
Catalog No.:BCC3689
CAS No.:602306-29-6
- Tetrahydropalmatine Hydrochloride
Catalog No.:BCN8335
CAS No.:6024-85-7
- (±)-Nipecotic acid
Catalog No.:BCC6576
CAS No.:60252-41-7
- Ethyl(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate
Catalog No.:BCN1405
CAS No.:60263-06-1
- H-D-HoSer-OH
Catalog No.:BCC3243
CAS No.:6027-21-0
- Aspalathin
Catalog No.:BCC8122
CAS No.:6027-43-6
- Guanosine-2'(3')-monophosphate disodium salt
Catalog No.:BCC3608
CAS No.:6027-83-4
- Guvacine hydrochloride
Catalog No.:BCC6574
CAS No.:6027-91-4
- Gestodene
Catalog No.:BCC4490
CAS No.:60282-87-3
Synthesis of 2-acetyl-1,4-dimethoxynaphthalene, a potential intermediate for disubstituted naphtho[2,3,c]pyran-5,10-dione.[Pubmed:24689294]
Nat Prod Commun. 2014 Feb;9(2):217-8.
2-Acetyl-1-hydroxynaphthalene was converted into the title compound in three steps (bromination, substitution and methylation). 1-Methoxynaphthalene on bromination, substitution and acetylation, respectively, also yielded the target compound.
Synthesis of 1,4-anthracene-9,10-dione derivatives and their regulation of nitric oxide, IL-1beta and TNF-alpha in activated RAW264.7 cells.[Pubmed:23819539]
Chem Biol Drug Des. 2013 Oct;82(4):463-7.
Mitoxantrone is an anthracenedione antineoplastic and immunosuppressive agent approved for multiple sclerosis treatment. Novel mono- and disubstituted anthraquinone derivatives, analogues of mitoxantrone, were synthesized through the addition of lipophilic amino alcohols and evaluated for their effect on IL-1beta, TNF-alpha and nitric oxide production by LPS/IFN-gamma-stimulated RAW264.7 cells. The disubstituted 1,4-anthracene-9,10-dione 10 showed significant inhibition of nitric oxide, TNF-alpha and IL-1beta production at the concentration of 5 mug/mL, with a much lower cytotoxicity than mitoxantrone. The monosubstituted 3, 4, 11, 12 and 13 also displayed a moderate to good inhibitory capacity on IL-1beta production. However, the methylated compounds 11, 12 and 13 failed to inhibit the TNF-alpha production, and compound 13 was the only one to decrease the production of nitric oxide. None of these derivatives was toxic at the tested concentrations. Compounds 10 and 13 had better inhibitory capacity of the inflammatory mediators analyzed, with reliable viability of the cells.
Spectroscopic studies of 1,4-dimethoxy-2,3-dimethylanthracene-9,10-dione on plasmonic silver nanoparticles.[Pubmed:24973788]
Spectrochim Acta A Mol Biomol Spectrosc. 2014 Dec 10;133:472-9.
Silver nanoparticles (Ag NPs) of different sizes from 7nm to 22nm have been prepared by simple Dirk and Charles chemical method and characterized using UV-vis spectroscopy and high resolution transmission electron microscopy (HRTEM). Fluorescence quenching of 1,4-dimethoxy-2,3-dimethylanthracene-9,10-dione (DMDMAD) by silver nanoparticles has been investigated by fluorescence spectroscopy to understand the role of quenching mechanism. Furthermore, the intensity of DMDMAD fluorescence emission peak decreases with decrease in the size of the Ag NPs. The fluorescence quenching rate constant and association constant for above system were determined using Stern-Volmer and Benesi-Hildebrand plots. The mechanism of DMDMAD fluorescence quenched by Ag NPs was discussed according to the Stern-Volmer equation. It has been observed that the quenching due to Ag NPs proceeds via dynamic quenching process. The distance between DMDMAD (donor) to Ag NPs (acceptor) and the critical energy transfer distance were estimated based on the Forster Resonance Energy Transfer (FRET) theory.
Spectroscopic (FT-IR, FT-Raman), first order hyperpolarizability, NBO analysis, HOMO and LUMO analysis of 2,4-bis(2-methoxyphenyl)-1-phenylanthracene-9,10-dione by ab initio HF and density functional methods.[Pubmed:24012980]
Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jan 3;117:413-21.
Anthraquinone derivatives are most important class of a system that absorb in the visible region. In this work, the vibrational spectral analysis was carried out using FT-IR and FT-Raman spectroscopy for 2,4-bis(2-methoxyphenyl)-1-phenylanthracene-9,10-dione. Theoretical calculations were performed by ab initio HF and DFT methods using 6-31G(*) basis set. The complete vibrational assignments of wavenumbers were made on the basis of potential energy distribution. The HOMO and LUMO analysis is used to determine the charge transfer within the molecule. The stability of the molecule arising from hyper-conjugative interaction and charge delocalization has been analyzed using NBO analysis. The calculated geometrical parameters (DFT) are in agreement with that of similar derivatives. The calculated first hyperpolarizability of the title compound is 4.69x10(-30) esu, which is 36.08 times that of urea and the title compound and the series of compounds it represents are attractive candidates for further studies in non linear optical applications.